Logo

American Heart Association

  2
  0


Final ID: MDP428

Comparative performance of PREVENT and Pooled Cohort Equations to predict cardiovascular disease in multisite healthcare populations

Abstract Body (Do not enter title and authors here): Introduction
The American Heart Association’s race-agnostic Predicting Risk of cardiovascular EVENTs (PREVENT) framework has emerged to better capture multilevel determinants of health in contemporary population. Whether PREVENT better predicts incident atherosclerotic cardiovascular disease (ASCVD) than the preceding Pooled Cohort Equations (PCE) is unknown in healthcare populations. We evaluated calibration and discrimination of the two equations across three major U.S. healthcare networks.

Methods
We retrospectively evaluated electronic health records of 209,879 individuals (Mass General Brigham [MGB]: 118,801; Mount Sinai Healthcare System: 38,834; Penn Medicine: 52,424) aged 40-79 years and without prior ASCVD between 2010-2012. Calibration was assessed using discordance ratio between 10-year observed and predicted risk. Discrimination was evaluated by Harrell’s C-index.

Results
Based on PREVENT, the mean [SD] estimated 10-year ASCVD risk ranged from 5.5 [4.7] % in MGB (mean age 56y, 42% female), 6.6 [5.6]% in Mount Sinai (59y, 54% female), and 6.4 [5.2]% in Penn (60y, 55% female). PREVENT substantially underestimated empirical 10-year ASCVD incidence in MGB (16.9%) and Mount Sinai (10.9%), whereas it closely mirrored the observed rate in Penn (5.5%). Both PCE and PREVENT had comparable discrimination C-index [95% CI] across MGB (0.69 [0.69-0.70] vs. 0.69 [0.68-0.69]), Mount Sinai (0.72 [0.71-0.73] vs. 0.70 [0.70-0.71]), and Penn (0.68 [0.67-0.69] vs. 0.67 [0.66-0.68]). Nevertheless, compared to PREVENT, PCE demonstrated better overall calibration in MGB (-70% vs. -42%) and Mount Sinai (-36% vs. +5%), whereas largely overestimated risk in Penn (+3% vs +94%). Calibration varied across demographics with PREVENT consistently underestimating risk in Hispanics, Asians, Black and African Americans across all sites, whereas PCE largely overestimated risk for White or multiracial Penn healthcare patients.

Conclusions
The race-agnostic PREVENT model discriminated ASCVD incidence comparably or better than the race-informed PCE across three geographically distinct academic health systems in the Northeast. However, calibration metrics between the two models varied widely across health systems and demographics.
  • Cho, So Mi  ( Massachusetts General Hospital , Cambridge , Massachusetts , United States )
  • Damrauer, Scott  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
  • Do, Ron  ( Icahn School of Medicine at Mount Sinai , New York , New York , United States )
  • Natarajan, Pradeep  ( Massachusetts General Hospital , Brookline , Massachusetts , United States )
  • Levin, Michael  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
  • Chen, Robert  ( Icahn School of Medicine at Mount Sinai , New York , New York , United States )
  • Judy, Renae  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
  • Postupaka, Darina  ( Massachusetts General Hospital , Cambridge , Massachusetts , United States )
  • Viscosi, Victoria  ( Massachusetts General Hospital , Cambridge , Massachusetts , United States )
  • Fahed, Akl  ( Massachusetts General Hospital , Cambridge , Massachusetts , United States )
  • Honigberg, Michael  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Hornsby, Whitney  ( Massachusetts General Hospital , Cambridge , Massachusetts , United States )
  • Author Disclosures:
    So Mi Cho: DO NOT have relevant financial relationships | Scott Damrauer: DO have relevant financial relationships ; Research Funding (PI or named investigator):Novo Nordisk:Active (exists now) ; Research Funding (PI or named investigator):Renalytix:Past (completed) | Ron Do: No Answer | Pradeep Natarajan: DO have relevant financial relationships ; Researcher:Allelica:Active (exists now) ; Advisor:Preciseli:Active (exists now) ; Advisor:MyOme:Active (exists now) ; Advisor:Esperion Therapeutics:Active (exists now) ; Advisor:TenSixteen Bio:Active (exists now) ; Consultant:Novartis:Active (exists now) ; Consultant:Genentech / Roche:Active (exists now) ; Consultant:Eli Lilly & Co:Active (exists now) ; Researcher:Novartis:Active (exists now) ; Researcher:Genentech / Roche:Active (exists now) | Michael Levin: DO have relevant financial relationships ; Research Funding (PI or named investigator):Myome:Active (exists now) | Robert Chen: No Answer | Renae Judy: No Answer | Darina Postupaka: No Answer | Victoria Viscosi: DO NOT have relevant financial relationships | Akl Fahed: No Answer | Michael Honigberg: DO have relevant financial relationships ; Advisor:Miga Health:Active (exists now) ; Research Funding (PI or named investigator):Novartis:Expected (by end of conference) ; Consultant:Comanche Biopharma:Past (completed) ; Research Funding (PI or named investigator):Genentech:Active (exists now) | Whitney Hornsby: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Predictive Precision: Unlocking Cardiovascular Health with PREVENT Risk Scoring

Saturday, 11/16/2024 , 11:10AM - 12:35PM

Moderated Digital Poster Session

More abstracts on this topic:
Assessing the Role of Thyroid Function in Ischemic Stroke: A Retrospective Analysis Across TOAST Classification

Singh Zamir, Bozkurt Subutay, Haimi Joshua, Siddiqui Mariah, Briski Nicholas, Strauss Sara

Analysing the Global Landscape of Hypertension-Related Aortic Aneurysm Mortality: Insights from 31-Year Analysis of Global Burden Of Disease 2021

Shaukat Muhammad Talha, Rehman Wania, Mohsin Aleenah, Rehman Aqeeb Ur, Rahman Saad Ur, Qureshi Muhammad Ahmad, Mohsin Ali

More abstracts from these authors:
A Hypertrophic Cardiomyopathy Polygenic Score Modifies Penetrance of Pathogenic Hypertrophic and Dilated Cardiomyopathy Variants in Opposite Directions

Abramowitz Sarah, Hoffman-andrews Lily, Depaolo John, Judy Renae, Owens Anjali, Damrauer Scott, Levin Michael

Integrative Metabolomic Analysis of Triglyceride-Independent Lipoprotein Lipase Pathway Mechanisms for Coronary Artery Disease

Dron Jacqueline, Xue Liying, Koyama Satoshi, Schuermans Art, Lee Jiwoo, Honigberg Michael, Hornsby Whitney, Peloso Gina, Natarajan Pradeep

You have to be authorized to contact abstract author. Please, Login
Not Available